Korea South
Peptron, Inc., founded in 1997 and headquartered in South Korea, is making strides in the biotechnology and health care industries. Known for its slogan, "Revolutionizing Patient Care via 'Cozy-Cure': Better Treatments, Enhanced Patient Lives," Peptron specializes in developing long-acting injectable formulations for peptide-based therapeutics through its proprietary SmartDepot™ platform.
This innovation is designed to transform frequent treatments into monthly dosing, thereby improving patient compliance and quality of life without modifying the active pharmaceutical ingredient. The company's robust pipeline includes Leupone™ for precocious puberty, gynecology, and oncology; long-acting formulations for Diabetes & Obesity with PT403/PT404; PT320 for Parkinson's Disease; and their novel antibody PAb001 targeting cancer therapy.
Last receiving venture round investment in 2014 from Innopolis Partners and Agate Medical Investments, Peptron offers attractive partnership models, accelerating development timelines for potential global collaborators.
